The fee for a Malaysian is RM30 for an antibody rapid test kit, RM60 for an antigen rapid test kit, RM150 for a polymerase chain reaction test kit; while for foreigners, the fees stated in the regulations are RM60 (antibody rapid test kit), RM120 (antigen rapid test kit), RM250 (polymerase chain reaction test kit).
The fee for a Malaysian is RM30 for an antibody rapid test kit, RM60 for an antigen rapid test kit, RM150 for a polymerase chain reaction test kit; while for foreigners, the fees stated in the regulations are RM60 (antibody rapid test kit), RM120 (antigen rapid test kit), RM250 (polymerase chain reaction test kit).
(Nov 22): The Teratai cluster, which is linked to the world's largest glove manufacturer Top Glove Corp Bhd, now has more than 1,000 Covid-19 cases, according to the Ministry of Health (MoH).
Today, the Teratai cluster reported 504 new cases, pushing the current tally of total infections in the cluster to 1,457.
Forget about Mtouche. The next flying stock is ISTONE. Look at the volume and buy queue today. I have been monitoring this stock for weeks. Operator gona push this gem to at least 0.3 Board before it is too late
everyone is still waiting for this wednesday's show by muhyddin. Medical counter should be safe, just basic sentimental of investors waiting for confirmed news. Today and tomorrow morning should hv no drastic change of price, everyone holding for the best opportunity.
(Nov 22): The Teratai cluster, which is linked to the world's largest glove manufacturer Top Glove Corp Bhd, now has more than 1,000 Covid-19 cases, according to the Ministry of Health (MoH).
Today, the Teratai cluster reported 504 new cases, pushing the current tally of total infections in the cluster to 1,457.
Reference is made to Kanger’s announcement on 29 September 2020 (ref no. GA1-29092020-00043) whereby the Group had entered into a three-year collaboration agreement with Sinopharm Group Hunan Changde Medical Co Ltd for the distribution of Covid-19 vaccines and medical equipment in Malaysia which are developed by China National Pharmaceutical Group Corporation (“Sinopharm”).
The Board of Directors of Kanger is pleased to announce that National Institutes of Biotechnology Malaysia (“NIBM”), an agency under the Ministry of Science, Technology and Innovation Malaysia has issued a letter which states that NIBM has no objections for Kanger to communicate with the relevant stakeholders at Sinopharm to purchase Covid-19 vaccines for private sector use in Malaysia.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
SuiChaBo
96 posts
Posted by SuiChaBo > 2020-11-23 08:56 | Report Abuse
Fuk everyone want it drop and keep secretly really diao niama.